Aquestive Therapeutics
AQST
AQST
57 hedge funds and large institutions have $48.1M invested in Aquestive Therapeutics in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+10
Holders Change %
+21.28%
% of All Funds
0.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
17
Reduced
13
Closed
5
Calls
$339K
Puts
$86K
Net Calls
+$253K
Net Calls Change
+$4K
Top Buyers
1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.71M |
2 |
LCM
Legato Capital Management
San Francisco,
California
|
+$688K |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$385K |
4 |
Citadel Advisors
Miami,
Florida
|
+$334K |
5 |
Jane Street
New York
|
+$315K |